Cost-Effectiveness Modelling of Sofosbuvir-Containing Regimens for Chronic Genotype 5 Hepatitis C Virus Infection in South Africa.
about
Introduction and Utilization of High Priced HCV Medicines across Europe; Implications for the FutureSystematic review: cost-effectiveness of direct-acting antivirals for treatment of hepatitis C genotypes 2-6.Assessing the Effect of Potential Reductions in Non-Hepatic Mortality on the Estimated Cost-Effectiveness of Hepatitis C Treatment in Early Stages of Liver Disease.Adapting Pharmacoeconomics to Shape Efficient Health Systems en Route to UHC - Lessons from Two Continents.The investment case for hepatitis B and C in South Africa: adaptation and innovation in policy analysis for disease program scale-up.Population Health and Cost-Effectiveness Implications of a "Treat All" Recommendation for HCV: A Review of the Model-Based Evidence
P2860
Cost-Effectiveness Modelling of Sofosbuvir-Containing Regimens for Chronic Genotype 5 Hepatitis C Virus Infection in South Africa.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Cost-Effectiveness Modelling o ...... rus Infection in South Africa.
@en
type
label
Cost-Effectiveness Modelling o ...... rus Infection in South Africa.
@en
prefLabel
Cost-Effectiveness Modelling o ...... rus Infection in South Africa.
@en
P2093
P2860
P1433
P1476
Cost-Effectiveness Modelling o ...... irus Infection in South Africa
@en
P2093
George Dranitsaris
Ilanca Fraser
Mark Sonderup
Tienie Stander
P2860
P2888
P304
P356
10.1007/S40273-015-0356-X
P577
2016-04-01T00:00:00Z